Annual Financials for Bio-Techne Corp.
Fiscal year is July-June. All values USD millions. |
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
Sales/Revenue
|
499.02M | 563M | 642.99M | 714.01M | 738.69M | |
Sales Growth |
- | 12.82% | 14.21% | 11.04% | 3.46% | |
Cost of Goods Sold (COGS) incl. D&A |
180.66M | 209.79M | 232.5M | 285.37M | 282.1M | |
COGS excluding D&A |
137.9M | 149.75M | 168.04M | 207.2M | 199.36M | |
Depreciation & Amortization Expense |
42.76M | 60.04M | 64.46M | 78.17M | 82.74M | |
Depreciation |
13.36M | 15.61M | 17.51M | 19.46M | 21.64M | |
Amortization of Intangibles |
29.4M | 44.43M | 46.95M | 58.72M | 61.1M | |
COGS Growth |
- | 16.12% | 10.83% | 22.74% | -1.15% | |
Gross Income |
318.36M | 353.21M | 410.49M | 428.64M | 456.59M | |
Gross Income Growth |
- | 10.95% | 16.22% | 4.42% | 6.52% | |
Gross Profit Margin |
- | - | - | - | 61.81% | NA |
|
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
SG&A Expense |
165.01M | 206.84M | 249.51M | 299.09M | 299.58M | |
Research & Development |
45.19M | 53.51M | 55.33M | 62.41M | 65.19M | |
Other SG&A |
119.82M | 153.33M | 194.18M | 236.68M | 234.39M | |
SGA Growth |
- | 25.35% | 20.63% | 19.87% | 0.16% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
2.76M | 25.79M | 24.81M | 18.35M | (403,000) | |
EBIT after Unusual Expense |
150.59M | (25.79M) | 136.18M | 111.19M | 157.42M | |
Non Operating Income/Expense |
(1.61M) | (1.57M) | (447,000) | 21.96M | 133.15M | |
Non-Operating Interest Income |
249,000 | 304,000 | 409,000 | 569,000 | 605,000 | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
1.75M | 7.36M | 10.19M | 21.71M | 14.69M | |
Interest Expense Growth |
- | 321.11% | 38.41% | 113.04% | -32.30% | |
Gross Interest Expense |
1.75M | 7.36M | 10.19M | 21.71M | 14.69M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
147.48M | 111.96M | 125.95M | 112.02M | 276.48M | |
Pretax Income Growth |
- | -24.08% | 12.50% | -11.07% | 146.82% | |
Pretax Margin |
- | - | - | - | 37.43% | NA |
Income Tax |
43.01M | 35.88M | (198,000) | 15.94M | 47.18M | |
Income Tax - Current Domestic |
37.76M | 32.51M | 33.73M | 16.63M | 24.99M | |
Income Tax - Current Foreign |
7.58M | 8.21M | 11.98M | 13.33M | 8.58M | |
Income Tax - Deferred Domestic |
1.48M | (1.87M) | (41.76M) | (10.88M) | 16.13M | |
Income Tax - Deferred Foreign |
(3.82M) | (2.98M) | (4.15M) | (3.14M) | (2.52M) | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | (65,000) | (108,000) | (105,000) | (224,000) | |
Consolidated Net Income |
104.48M | 76.02M | 126.04M | 95.97M | 229.07M | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
104.48M | 76.02M | 126.04M | 95.97M | 229.07M | |
Net Income Growth |
- | -27.24% | 65.80% | -23.86% | 138.70% | |
Net Margin Growth |
- | - | - | - | 31.01% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
104.48M | 76.02M | 126.04M | 95.97M | 229.07M | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
104.48M | 76.02M | 126.04M | 95.97M | 229.07M | |
EPS (Basic) |
2.81 | 2.04 | 3.36 | 2.54 | 6.00 | |
EPS (Basic) Growth |
- | -27.49% | 65.08% | -24.48% | 136.07% | |
Basic Shares Outstanding |
37.19M | 37.31M | 37.48M | 37.78M | 38.2M | |
EPS (Diluted) |
2.80 | 2.03 | 3.31 | 2.47 | 5.81 | |
EPS (Diluted) Growth |
- | -27.60% | 63.38% | -25.50% | 135.62% | |
Diluted Shares Outstanding |
37.33M | 37.5M | 38.06M | 38.89M | 39.4M | |
EBITDA |
196.12M | 206.41M | 225.45M | 207.72M | 239.75M | |
EBITDA Growth |
- | 5.25% | 9.22% | -7.86% | 15.42% | |
EBITDA Margin |
- | - | - | - | 32.46% | NA |